Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA_1c). The Tromsø Study

References

• Maalouf NM. The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens 2008;17:408–15.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266–81.
   PubMed Web of Science ®Google Scholar
• Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004;89/90:121–5.
   Web of Science ®Google Scholar
• Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980;209:823–5.
   PubMed Web of Science ®Google Scholar
• Nyomba BL, Bouillon R, De Moor P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 1984;115:191–7.
   PubMed Web of Science ®Google Scholar
• Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986;119:84–90.
   PubMed Web of Science ®Google Scholar
• Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003;17:509–11.
   PubMed Web of Science ®Google Scholar
• Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995;27:181–8.
   PubMed Web of Science ®Google Scholar
• Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27: 2813–8.
   PubMed Web of Science ®Google Scholar
• Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, Rissanen H, Montonen J, Reunanen A. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666–71.
   PubMed Web of Science ®Google Scholar
• Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 2005;62:738–41.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820–5.
   PubMed Web of Science ®Google Scholar
• Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139:329–34.
   PubMed Web of Science ®Google Scholar
• Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997;40:344–7.
   PubMed Web of Science ®Google Scholar
• Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, Hanley AJ. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33:1379–81.
   PubMed Web of Science ®Google Scholar
• Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003;57:258–61.
   PubMed Web of Science ®Google Scholar
• Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57:183–91.
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 2008;57:2619–25.
   PubMed Web of Science ®Google Scholar
• Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007;24:333–43.
   PubMed Web of Science ®Google Scholar
• McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008;7:4.
   PubMed Web of Science ®Google Scholar
• Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1c levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey. Diabetes Care 2010;33:1236–8.
   PubMed Web of Science ®Google Scholar
• Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006;29:2244–6.
   PubMed Web of Science ®Google Scholar
• Thelle DS, Foerde OH, Try K, Lehmann EH. The Tromsoe heart study. Methods and main results of the cross-sectional study. Acta Med Scand 1976;200:107–18.
   PubMedGoogle Scholar
• Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002;137:263–72.
   PubMed Web of Science ®Google Scholar
• Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R. Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 2010;163:339–48.
   PubMed Web of Science ®Google Scholar
• Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010; 171:903–8.
   PubMed Web of Science ®Google Scholar
• Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. Serum 25- hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010;55:792–8.
   PubMed Web of Science ®Google Scholar
• Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006;368:1–19.
   PubMed Web of Science ®Google Scholar
• Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298–305.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, Hashimoto S, Itoh M. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 2006;53:503–10.
   PubMed Web of Science ®Google Scholar
• Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157–61.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Horst RL, Cullen DM, Armas LA. Vitamin D3 distribution and status in the body. J Am Coll Nutr 2009; 28:252–6.
   PubMed Web of Science ®Google Scholar
• Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690–3.
   PubMed Web of Science ®Google Scholar
• Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983;113:1511–8.
   PubMed Web of Science ®Google Scholar
• Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002;51:2294–300.
   PubMed Web of Science ®Google Scholar
• Ortlepp JR, Metrikat J, Albrecht M, von Korff A, Hanrath P, Hoffmann R. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 2003;20:451–4.
   PubMed Web of Science ®Google Scholar
• Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002;51:356–9.
   PubMed Web of Science ®Google Scholar
• Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986;29:142–5.
   PubMed Web of Science ®Google Scholar
• Manco M, Calvani M, Nanni G, Greco AV, Iaconelli A, Gasbarrini G, Castagneto M, Mingrone G. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 2005;13:1692–700.
   PubMedGoogle Scholar
• Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A. 25-hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity 2010;18:1906–10.
   PubMed Web of Science ®Google Scholar
• Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Risérus U, Roche HM, Drevon CA, Birkeland KI. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010;33:923–5.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007;30:980–6.
   PubMed Web of Science ®Google Scholar
• Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 1989; 11:141–7.
   PubMedGoogle Scholar
• Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995;38:1239–45.
   PubMed Web of Science ®Google Scholar
• Tai K, Need AG, Horowitz M, Chapman IM. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008;24:950–6.
   PubMed Web of Science ®Google Scholar
• McLaughlin M, Raggatt PR, Fairney A, Brown DJ, Lester E, Wills MR. Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet 1974; 1:536–8.
   PubMed Web of Science ®Google Scholar
• Ferrie CD, Sharpe TC, Price DA, Surtees RA. Seasonal variation of glycosylated haemoglobin. Arch Dis Child 1987;62:959–60.
   PubMed Web of Science ®Google Scholar
• Higgins T, Saw S, Sikaris K, Wiley CL, Cembrowski GC, Lyon AW, Khajuria A, Tran D. Seasonal variation in hemoglobin A1c: is it the same in both hemispheres? J Diabetes Sci Technol 2009;3:668–71.
   PubMedGoogle Scholar
• Tseng CL, Brimacombe M, Xie M, Rajan M, Wang H, Kolassa J, Crystal S, Chen TC, Pogach L, Safford M. Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol 2005;161:565–74.
   PubMed Web of Science ®Google Scholar
• Hawkins RC. Circannual variation in glycohemoglobin in Singapore. Clin Chim Acta 2010;411:18–21.
   PubMed Web of Science ®Google Scholar
• Bartelink ML, Hoek L, Freriks JP, Rutten GE. Infections in patients with type 2 diabetes in general practice. Diabetes Res Clin Pract 1998;40:15–9.
   PubMed Web of Science ®Google Scholar